Milestone Pharmaceuticals Inc.
MISTAs of the close on Sep 25, 2026
Price
$0.79
Market cap
$98.2M
P/E (diluted TTM)
—
Not meaningful: the last four quarters were a loss
EPS (TTM)
−$0.65
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Milestone Pharmaceuticals Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 12, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 2026-03-31 | 59,620 | Not shown | SEC filing |
| Russell Investments Group, Ltd. | 2026-03-31 | 125 | Not shown | SEC filing |
| Wealthspire Advisors, LLC | 2026-03-31 | 10,629 | Not shown | SEC filing |
| Bayesian Capital Management, LP | 2026-03-31 | 10,015 | Not shown | SEC filing |
| Invesco Ltd. | 2026-03-31 | 41,356 | Not shown | SEC filing |
| GROUP ONE TRADING LLC | 2026-03-31 | 129,764 | Not shown | SEC filing |
| Creative Planning | 2026-03-31 | 13,410 | Not shown | SEC filing |
| GSA CAPITAL PARTNERS LLP | 2026-03-31 | 26,893 | Not shown | SEC filing |
| Boxer Capital Management, LLC | 2026-03-31 | 666,666 | Not shown | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 159,669 | Not shown | SEC filing |
| Eaton Financial Holdings Company, LLC | 2026-03-31 | 10,250 | Not shown | SEC filing |
| SG Americas Securities, LLC | 2026-03-31 | 42,512 | Not shown | SEC filing |
| Strategic Family Wealth Counselors, L.L.C. | 2026-03-31 | 13,875 | Not shown | SEC filing |
| ACADIAN ASSET MANAGEMENT LLC | 2026-03-31 | 20,468 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 40,789 | Not shown | SEC filing |
| Mariner, LLC | 2026-03-31 | 30,830 | Not shown | SEC filing |
| Seven Fleet Capital Management LP | 2026-03-31 | 333,333 | Not shown | SEC filing |
| SIMPLEX TRADING, LLC | 2026-03-31 | 149,291 | Not shown | SEC filing |
| Aptus Capital Advisors, LLC | 2026-03-31 | 280,250 | Not shown | SEC filing |
| Bay Rivers Group | 2026-03-31 | 29,911 | Not shown | SEC filing |
- Each value is checked against Milestone Pharmaceuticals Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: the value per share could not be confirmed against the share prices on file from within three months of the report date.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Tower Research Capital LLC (TRC): 8,980 shares reported 2025-12-31; 9,147 shares reported 2026-03-31.
- STATE STREET CORP: 21,875 shares reported 2025-12-31; 22,331 shares reported 2026-03-31.
- TWO SIGMA INVESTMENTS, LP: 1,514,461 shares reported 2025-12-31; 2,317,176 shares reported 2026-03-31.
- Cetera Investment Advisers: 20,722 shares reported 2025-12-31; 14,704 shares reported 2026-03-31.
- SUSQUEHANNA INTERNATIONAL GROUP, LLP: 643,300 shares reported 2025-12-31; 519,046 shares reported 2026-03-31.
- Safeguard Investment Advisory Group, LLC: 25,044 shares reported 2025-12-31; 25,044 shares reported 2026-03-31.
- Medallion Wealth Advisors, LLC: 340 shares reported 2025-12-31; 340 shares reported 2026-03-31.
- SBI Securities Co., Ltd.: 6 shares reported 2025-12-31; 11 shares reported 2026-03-31.
- Ancora Advisors LLC: 10,000 shares reported 2025-12-31; 10,000 shares reported 2026-03-31.
- Rockefeller Capital Management L.P.: 1,700 shares reported 2025-12-31; 12,500 shares reported 2026-03-31.
- SJS Investment Consulting Inc.: 15,000 shares reported 2025-12-31; 15,000 shares reported 2026-03-31.
- NORTHERN TRUST CORP: 39,258 shares reported 2025-12-31; 38,779 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
61 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Milestone Pharmaceuticals Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-12-15 · Oliveto Joseph: Larger than 12 of the 13 other insider sales of Common Shares on file. SEC filing
- 2022-09-07 · RTW INVESTMENTS, LP: Larger than all 13 other insider sales of Common Shares on file. SEC filing
- 2019-11-20 · RTW INVESTMENTS, LP: Larger than 20 of the 22 other insider purchases of Common Shares on file. SEC filing
- 2019-05-13 · FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC: Larger than 21 of the 22 other insider purchases of Common Shares on file. SEC filing
- 2019-05-09 · RTW INVESTMENTS, LP: Larger than all 22 other insider purchases of Common Shares on file. SEC filing
Independent insiders buying near the same time
- 2022-10-19–2022-10-21: 5 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
- 2019-05-08–2019-05-13: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-04-16 | Oliveto Joseph · President and CEO | Common Shares | S — Open market or private sale | −36,500 | 2.26 | SEC filing |
| 2026-01-26 | Muller Lorenz · Chief Commercial Officer | Common Shares | S — Open market or private sale | −11,180 | 1.93 | SEC filing |
| 2026-01-26 | Bharucha David · Chief Medical Officer | Common Shares | S — Open market or private sale | −12,245 | 1.93 | SEC filing |
| 2026-01-26 | Hasija Amit · CFO & EVP of Corp. Development | Common Shares | S — Open market or private sale | −12,245 | 1.93 | SEC filing |
| 2026-01-26 | Nelson Jeffrey Edward · Chief Operating Officer | Common Shares | S — Open market or private sale | −12,245 | 1.93 | SEC filing |
| 2026-01-26 | Oliveto Joseph · President and CEO | Common Shares | S — Open market or private sale | −34,523 | 1.93 | SEC filing |
| 2026-01-08 | Oliveto Joseph · President and CEO | Common Shares | S — Open market or private sale | −43,000 | 2.25 | SEC filing |
| 2026-01-07 | Oliveto Joseph · President and CEO | Common Shares | S — Open market or private sale | −500 | 2.25 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-10 | Saik Andrew · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +77,000 | SEC filing |
| 2026-06-10 | Fischer Seth H. Z. · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +77,000 | SEC filing |
| 2026-06-10 | Wills Robert James · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +77,000 | SEC filing |
| 2026-06-10 | TOMSICEK MICHAEL JOHN · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +77,000 | SEC filing |
| 2026-06-10 | Duty Stuart · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +77,000 | SEC filing |
| 2026-06-10 | Giles Lisa M. · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +77,000 | SEC filing |
| 2026-06-10 | PAPA JOSEPH C · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +77,000 | SEC filing |
| 2026-02-02 (amended) | Bharucha David · Chief Medical Officer | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +204,000 | SEC filing |
Showing 8 of 21 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2023-03-22 | RTW INVESTMENTS, LP · 10% owner | Common Shares, no par value ("Common Shares") | J — Other acquisition or disposition | −1,059,000 | SEC filing |
| 2022-09-14 | Liebert Debra K. · Director | Common Shares | J — Other acquisition or disposition | +127 | SEC filing |
Showing 2 of 2 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.